Cargando…

miR‐548ag functions as an oncogene by suppressing MOB1B in the development of obesity‐related endometrial cancer

Obesity is a high‐risk factor in the development of endometrial cancer (EC). Our previous study observed that miR‐548ag was significantly overexpressed in the sera of obese individuals. Here, we report the function of miR‐548ag and its mechanism in promoting the obesity‐related progression of EC. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Huai, Wang, Jingzhou, Wei, Qianqian, Liu, Jie, Chu, Xiaolong, Yuan, Chenggang, Yang, Bingqi, Li, Menghuan, Ma, Dingling, Tang, Yihan, Wang, Cuizhe, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067393/
https://www.ncbi.nlm.nih.gov/pubmed/36445107
http://dx.doi.org/10.1111/cas.15679
Descripción
Sumario:Obesity is a high‐risk factor in the development of endometrial cancer (EC). Our previous study observed that miR‐548ag was significantly overexpressed in the sera of obese individuals. Here, we report the function of miR‐548ag and its mechanism in promoting the obesity‐related progression of EC. The content of miR‐548ag was increased in the serum of obese EC individuals. Bioinformatics analysis indicated that the survival rate of EC patients with a higher expression of miR‐548ag was significantly reduced. The Mps One Binder Kinase Activator 1B (MOB1B, the core member of the Hippo signaling pathway) is a direct target gene of miR‐548ag, which is inversely correlated with the expression of miR‐548ag. The overexpression of miR‐548ag enhances the proliferation, invasion, and migration, and inhibits apoptosis by downregulating the expression of MOB1B, leading to the deactivation of the Hippo pathway in EC cell lines and contributing to tumor progression in vivo. Our study has established that miR‐548ag functions as an oncogene by suppressing MOB1B in the development of obesity‐related EC.